Please ensure Javascript is enabled for purposes of website accessibility
Accessibility Menu
Xencor Stock Quote

Xencor (NASDAQ: XNCR)

$18.90
(-6.0%)
-$1.21
Price as of April 16, 2024, 2:13 p.m. ET

Xencor Return vs. S&P

1 Year 5 Year 5 Year Annualized Since IPO
XNCR -31.18% -35.25% -8.33% +141%
S&P +22.34% +74.52% +11.78% +182%

Xencor Company Info

Xencor, Inc. is a biopharmaceutical company, which engages in the development of engineered monoclonal antibody therapeutics to treat severe and life-threatening diseases. Its proprietary technology platform, XmAb, is used to create next-generation antibody product candidates designed to treat autoimmune and allergic diseases, cancer, and other conditions. The company was founded by Bassil I. Dahiyat and Stephen L. Mayo in August 1997 and is headquartered in Monrovia, CA.

News & Analysis

Valuation

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.